The Effectiveness of a Patient Self-reported Pain Scoring Tool and a Satisfaction Survey on Cancer Pain Management
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01829828|
Recruitment Status : Completed
First Posted : April 11, 2013
Last Update Posted : April 11, 2013
|Condition or disease||Intervention/treatment|
|Pain||Behavioral: No intervention|
|Study Type :||Observational|
|Actual Enrollment :||587 participants|
|Official Title:||To Evaluate the Effectiveness of a Patient Self-reported Pain Scoring Tool and a Satisfaction Survey on Cancer Pain Management; Multicenter, Cross-sectional Study|
|Study Start Date :||January 2012|
|Actual Primary Completion Date :||May 2012|
|Actual Study Completion Date :||May 2012|
Inpatients with cancer pain
Inpatients admitted for cancer pain management
Behavioral: No intervention
This is an observational study with no investigational drug administered.
- Patient satisfaction with the control of cancer-related pain [ Time Frame: At baseline ]Patients will answer on a 7-point scale how satisfied they feel about their cancer pain treatment. The scale scores range from 1 (not at all satisfied) to 7 (very much satisfied).
- Patient perception of pain [ Time Frame: At baseline ]Patients will answer on an 11-point scale how much pain they feel. The scales scores range from 0 (no pain at all) to 10 (pain as bad as you can imagine).
- Patient pain assessment by medical staff [ Time Frame: At baseline ]The patient's physician will mark on an 11-point scale the intensity of the patient pain. The scale scores range from 0 (no pain at all) to 10 (pain as bad as you can imagine).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01829828
|Study Director:||Janssen Korea, Ltd., Korea Clinical Trial||Janssen Korea, Ltd., Korea|